M&A / Deals McKesson to acquire Precision Medicine Group for $2.25bn Pharmaceutical TechnologyUS-based healthcare services provider McKesson has agreed to acquire Precision Medicine Group for $2.25bn.Read full story pharminent August 26, 2026 (Last updated: September 1, 2026) Pharmaceutical Technology US-based healthcare services provider McKesson has agreed to acquire Precision Medicine Group for $2.25bn. Read full story Post navigation Previous: FDA Approves J&J’s Imaavy for Warm Autoimmune Hemolytic Anemia, the First Therapy Ever Cleared in the DiseaseNext: Jazz secures FDA approval for Ziihera in advanced HER2+ GEA Related Stories M&A / Deals Exegenesis Bio and Modalis sign research deal for Duchenne therapy pharminent September 11, 2026 M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026